Skip Navigation
Skip to contents

Clin Endosc : Clinical Endoscopy

OPEN ACCESS

Search

Page Path
HOME > Search
2 "Dysbiosis"
Filter
Filter
Article category
Keywords
Publication year
Authors
Review
Alteration in gut microbiota after colonoscopy: proposed mechanisms and the role of probiotic interventions
Hyeong Ho Jo, Moon Young Lee, Se Eun Ha, Dong Han Yeom, Yong Sung Kim
Clin Endosc 2025;58(1):25-39.   Published online September 2, 2024
DOI: https://doi.org/10.5946/ce.2024.147
AbstractAbstract PDFPubReaderePub
Colonoscopy, a widely used procedure for diagnosing and treating colonic diseases, induces transient gastrointestinal symptoms and alterations in the gut microbiota. This review comprehensively examines the evidence on alterations in the gut microbiota following colonoscopy and their possible mechanisms. Factors such as rapid colonic evacuation, increased osmolality, and mucus thinning caused by bowel preparation and exposure to oxygen during the procedure contribute to these alterations. Typically, the alterations revert to the baseline within a short time. However, their long-term implications remain unclear, necessitating further investigation. Split-dose bowel preparation and CO2 insufflation during the procedure result in fewer alterations in the gut microbiota. Probiotic administration immediately after colonoscopy shows promise in reducing alterations and gastrointestinal symptoms. However, the widespread use of probiotics remains controversial due to the transient nature of both the symptoms and gut microbial alterations following a colonoscopy. Probiotics may offer greater benefits to individuals with preexisting gastrointestinal symptoms. Thus, probiotic administration may be a viable option for selected patients.

Citations

Citations to this article as recorded by  
  • Response to Ge and Chen
    Akira Higashimori, Natsumi Maeda, Yasuhiro Fujiwara
    American Journal of Gastroenterology.2025;[Epub]     CrossRef
  • Is It Advisable to Use Probiotics Routinely After a Colonoscopy? A Rapid Comprehensive Review of the Evidence
    Matteo Piciucchi, Alice Rossi, Alissa Satriano, Raffaele Manta
    Medical Sciences.2025; 13(2): 76.     CrossRef
  • Efficacy of Fecal Microbial Transplantation for Improving Symptoms of Irritable Bowel Syndrome - A Pilot Study for Voluntary Participants in Korea
    Jung Won Lee, Nayoung Kim
    The Korean Journal of Gastroenterology.2024; 84(4): 168.     CrossRef
  • 24,293 View
  • 816 Download
  • 1 Web of Science
  • 3 Crossref
Close layer
Focused Review Series: Future Perspectives of Fecal Microbiota Transplatation
Fecal Microbiota Transplantation beyond Clostridioides Difficile Infection
Chang Mo Moon, Sung Noh Hong
Clin Endosc 2021;54(2):149-151.   Published online March 26, 2021
DOI: https://doi.org/10.5946/ce.2021.068
AbstractAbstract PDFPubReaderePub
With advancing analytical methods for gut microbes, many studies have been conducted, revealing that gut microbes cause various diseases, including gastrointestinal and non-gastrointestinal diseases. Accordingly, studies have been actively conducted to analyze the effects on the prevention and treatment of these diseases through changes in intestinal microbes and control of dysbiosis. Fecal microbiota transplantation (FMT) is an effort and is currently being applied to Clostridioides difficile treatment in Korea. Many studies have demonstrated the application of FMT in inflammatory bowel disease, irritable bowel syndrome, non-alcoholic fatty liver disease, metabolic syndrome, obesity, and diabetes. With further studies and accumulation of evidence, FMT could help treat presently untreatable diseases in clinical practice.
  • 4,628 View
  • 122 Download
Close layer

Clin Endosc : Clinical Endoscopy Twitter Facebook
Close layer
TOP